等待开盘 08-08 09:30:00 美东时间
0.000
0.00%
今日重点评级关注:HC Wainwright & Co.:维持FibroGen"买入"评级,目标价从10美元升至43美元;摩根大通:维持Cogent Biosciences"超配"评级,目标价从29美元升至30美元
今天 09:34
今日重点评级关注:韦德布什:维持Gossamer Bio"跑赢大市"评级,目标价从4美元升至5美元;HC Wainwright & Co.:维持EyePoint Pharmaceuticals"买入"评级,目标价从22美元升至23美元
08-07 09:46
Barclays analyst Jeffrey Bernstein maintains Bloomin Brands (NASDAQ:BLMN) with a Equal-Weight and lowers the price target from $9 to $7.
08-07 03:41
Bloomin' Brands beats Q2 EPS estimates but suffers margin squeeze from inflation and guidance cuts, sending shares tumbling about 22%.
08-06 22:55
Bloomin Brands (NASDAQ:BLMN) is looking for Q3 Adj EPS of $(0.15)-$(0.10) vs $0.06 analyst estimate..
08-06 18:39
Bloomin Brands (NASDAQ:BLMN) lowers FY2025 Adj EPS guidance from $1.20-$1.40 to $1.00-$1.10 vs $1.21 analyst estimate..
08-06 18:38
Companies Reporting Before The Bell • Lineage (NASDAQ:LINE) is likely to report...
08-06 16:33
Bloomin’ Brands (NASDAQ:BLMN) announced Monday Eric Christel will assume the role of chief financial officer effective September 8 at the end of a transition period with current CFO, Michael Healy. C...
08-04 22:14
Bloomin’ Brands ( ($BLMN) ) has issued an update. On August 4, 2025, Bloomin’ B...
08-04 21:33